Month: April 2021

2024.07.17
Summary of the most important events and achievements of the Genomtec S.A.

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

2024.04.22
Dr. Trevor Hawkins, a distinguished entrepreneur, scientist, and leader with experience in global healthcare companies, has joined the Supervisory Board of Genomtec S.A.

2024.03.26
Genomtec secures PLN 10.6 million to fund scientific research and development of the oncology project - Company will raise capital from founding shareholders and investors

2024.03.26
Genomtec strengthens the Supervisory Board with individuals who bring extensive industry and business experience

Archive

2021.04.30

DCM DOLMED S.A. is becoming the reference laboratory for products offered by Genomtec S.A.

Company signed an agreement with the Lower Silesian Medical Center DOLMED S.A. – the leader of multidisciplinary healthcare provision in Wroclaw ...
Read
2021.04.22

Genomtec submits yet another patent application in the LAMP technology confirming implementation of its work plan dedicated to Genomtec ID

The patent application concerns the proprietary set of primers, the diagnostic method and the reaction mixture composition for genetic diagnosis ...
Read

Archive